Nutriband Inc. (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, announced that its CEO and co-founder, Gareth Sheridan, will present as part of the CEO Spotlight event at the 2026 Georgia Life Sciences Summit. The summit, scheduled for Aug. 25-26 at the Sandy Springs Performing Arts Centre in Sandy Springs, Georgia, convenes leaders across biotechnology, medical technology, research, manufacturing, and investment sectors.
The company is developing AVERSA™, an abuse-deterrent transdermal technology designed to incorporate aversive agents into patches to help prevent abuse, diversion, misuse, and accidental exposure involving drugs with abuse potential. This presentation comes at a time when the opioid crisis continues to challenge public health, and innovative solutions are sought to mitigate the risks associated with prescription drugs.
Nutriband’s lead product under development is an abuse-deterrent fentanyl patch incorporating the AVERSA™ technology. Fentanyl is a potent synthetic opioid, and its abuse potential is well-documented. By integrating aversive agents, the technology aims to make the patch less appealing for misuse, potentially reducing the incidence of addiction and overdose.
The Georgia Life Sciences Summit provides a platform for industry leaders to discuss advancements and collaborations. Sheridan’s participation underscores the significance of abuse-deterrent technologies in the broader context of pharmaceutical innovation. The summit’s focus on medical technology and research aligns with Nutriband’s mission to develop safer delivery systems for controlled substances.
Investors and industry observers will be watching closely, as the presentation could offer insights into the company’s progress and future plans. Nutriband’s commitment to addressing a critical public health issue is evident in its continued development of AVERSA™, which has the potential to set a new standard in transdermal drug safety.
The announcement follows Nutriband’s ongoing efforts to advance its pipeline and engage with key stakeholders in the life sciences community. The company’s participation in the summit is a strategic move to highlight its innovative approach and foster potential partnerships.
For more information about the summit and Nutriband’s involvement, visit the full press release. Details about Nutriband and its products can be found on the company’s website at www.nutriband.com. For the latest news and updates on NTRB, visit the company’s newsroom.
